Cathepsin B-sensitive nanoprobe for in vivo tumor diagnosis
- 12 October 2011
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry
- Vol. 21 (44) , 17631-17634
Abstract
We developed a cathepsin B-sensitive nanoprobe (CB-NP) with a cathepsin B substrate peptide probe and tumor-targeting glycol chitosan nanoparticles. The CB-NP could accumulate in tumor tissues, enter into tumor cells, and generate fluorescent signals in cytosol in response to cathepsin B. The results of non-invasive fluorescence imaging in a tumor-bearing mouse model demonstrated the potential of CB-NP for tumor diagnosis in clinical fields.Keywords
This publication has 23 references indexed in Scilit:
- Nanoprobes for biomedical imaging in living systemsNano Today, 2011
- Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoringJournal of Controlled Release, 2010
- Peptides and Peptide Hormones for Molecular Imaging and Disease DiagnosisChemical Reviews, 2010
- Near-infrared fluorescence: application to in vivo molecular imagingCurrent Opinion in Chemical Biology, 2010
- Noninvasive Quantitative Tomography of the Therapeutic Response to Dexamethasone in Ovalbumin-Induced Murine AsthmaThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Activatable imaging probes with amplified fluorescent signalsChemical Communications, 2008
- Emerging roles of proteases in tumour suppressionNature Reviews Cancer, 2007
- multifunctional enzymes in cancerNature Reviews Cancer, 2006
- Plasma membrane association of cathepsin B in human prostate cancer: Biochemical and immunogold electron microscopic analysisThe Prostate, 2001
- Fluorescent microplate assay for cancer cell‐associated cathepsin BEuropean Journal of Biochemistry, 2000